Aledade's $64M for tech-enabled ACOs, Alan's $54M for mobile-friendly insurtech and more digital health funding news

Also: RDMD locks in $14M for rare disease therapy research; VIDA Diagnostics raises $11M for AI lunch imaging analysis.
By Dave Muoio
03:58 pm

Aledade, a Bethesda, Maryland-based startup that partners with providers to build tech-enabled accountable care organizations, has raised $64 million in a Series C funding headed by OMERS Growth Equity. California Medical Association, Meritech Capital, Echo Health Ventures, CVF and GV also participated.

The company said these funds will help it to continue growing new and existing ACOs in addition to value-based contracts with public and commercial health plans. As of now, Aledade said that it is partnering with more than 500 independent practices and 7,300 providers.

“Our uniquely resilient business model – built on years of hard work, innovation and partnership – means that we have the resources during this difficult time to be able to support practices, and help them not only to survive, but to thrive," Dr. Farzad Mostashari, the former national coordinator for health IT, who now serves as Aledade's CEO and is a cofounder, said in a statement. "Aledade’s mission of always doing the right thing for patients, for doctors, and for society is now, and will continue to be, the core of our success as a business.”

French insurtech Alan has tied off a €50 million ($54.3 million) Series C round led by Temasek, with participation from Index Ventures. This brings the startup's total raise to €125 million (roughly $136 million).

Alan's health insurance platform looks to provide users with access to providers, information and other care support via its app. Some of these digital offerings include the Alan Map, which helps users find a practitioner and predicts the cost of their visit, and the Doctor Address Book, which stores the information of each of the user's doctors.

With the new funds, the company aims to launch additional services like these while expanding out of France into the rest of Europe.

RDMD, a Bay Area startup looks that employs personal health records to accelerate rare disease drug research, has locked in a $14 million Series A financing round. The raise was led by Spark Capital, with additional support from Lux Capital, Village Global, Garuda Ventures, Maveron Capital and a collection of angel investors.

The company posted a laundry list of plans for the new funds in its announcement, among which are expansions into 20 more rare diseases, new research study launches for these conditions, collaborative partnerships and team hires.

"We are also very excited to announce success in establishing industry partnerships and growth in our patient communities," Nancy Yu, CEO and cofounder of RDMD, said in a statement. "We have advanced from one condition focus to 12 conditions in less than two years, with plans to be in more than 30 conditions within a year. In a time of uncertainty for the world during the current COVID-19 pandemic, we want the rare disease patients and communities that we serve to know we are still working hard to make important progress in partnership with the entire rare disease community.”

VIDA Diagnostics, an artificial intelligence company powering lung-imaging analysis, has raised an $11 million Series C round. The raise was led by First Analysis Corporation, with participation from Blue Heron Capital, UnityPoint Health Ventures, Next Level Ventures, Chartline Capital Partners, the Rural Vitality Fund, Rittenhouse Ventures, Iowa First Capital Fund and the Angels' Forum.

The startup said that it will be expanding the clinical portfolio of its LungPrint platform.

"By equipping care teams with LungPrint, patient care and quality of life can be positively affected," Susan A. Wood, CEO of VIDA, said in a statement. "VIDA can now accelerate LungPrint's market access, further connecting its benefits to the many millions of patients with lung disease."

Yes Health, a smartphone platform that uses AI to support its human coaches, has brought in $6 million for its weight loss, nutrition counseling and diabetes prevention business. Khosla Ventures led the round.

The company said that it will be expanding its staff, fleshing out its platform and scaling its business.

At Yes Health, we've invested significantly to combine the best of Silicon Valley technology with the compassionate care of the best health care professionals to give back people control over their health," Alexander Petrov, founder and CEO of Yes Health, said in a statement. "Now more than ever it's crucial that we don't allow one health crisis to exacerbate others, needlessly driving up human suffering and societal cost."

Aaptiv, an app delivering trainer-led fitness workouts and wellness sessions, has raised new funds from Insight Partners, TechCrunch reports. The company did not disclose the value of its raise, but said that it will be used to flesh out its enterprise API offering that allows its classes to play through outside platforms.